BioNano Genomics, Inc Business Finance Contracts & Agreements
68 Contracts & Agreements
- Credit Agreements (1 contract)
- Investor Rights Agreements (4)
- Loan Agreements (11)
- Note Agreements (7)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Stock Agreements (15)
- Underwriting Agreements (7)
- Warrant Agreements (18)
- Form of Securities Purchase Agreement dated April 4, 2024 between Bionano Genomics, Inc. and the purchasers party thereto (Filed With SEC on April 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 5, 2024)
- Form of Warrant (Filed With SEC on April 5, 2024)
- Form of Common Stock Certificate (Filed With SEC on March 5, 2024)
- Amendment to Initial Registered Note issued to the Purchaser, dated February 27, 2024 (Filed With SEC on February 28, 2024)
- Securities Purchase Agreement, dated October 11, 2023, by and among the Company and the Purchaser named therein (Filed With SEC on October 11, 2023)
- Form of Warrant to Purchase Common Stock (Filed With SEC on October 11, 2023)
- Form of Note, representing the Companys Senior Secured Convertible Notes due 2025 (Filed With SEC on October 11, 2023)
- Purchase Agreement, dated April 13, 2023, by and between Bionano Genomics, Inc. and David Barker (Filed With SEC on April 14, 2023)
- Forms of double-trigger grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Forms of director grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Forms of grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Stock Restriction Agreement (Filed With SEC on March 1, 2022)
- Fourth Amendment to Loan and Security Agreement, dated December 30, 2020, by and among the Company, Lineagen, Inc., Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 23, 2021)
- Underwriting Agreement, dated January 20, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 21, 2021)
- Underwriting Agreement, dated January 8, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 11, 2021)
- Consent and Third Amendment to Loan and Security Agreement, dated August 21, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on November 13, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on March 24, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on March 24, 2020)
- Form of Underwriting Agreement (Filed With SEC on March 24, 2020)
- Second Amendment to Loan Agreement, dated March 6, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 10, 2020)
- Form of New Warrant (Filed With SEC on March 2, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 17, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 17, 2019)
- Form of Warrant to Purchase Common Stock (Filed With SEC on September 18, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2019)
- Waiver and First Amendment to Loan and Security Agreement, dated June 25, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on August 8, 2019)
- Loan and Security Agreement, dated March 14, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and the Lenders listed on Schedule 1.1 thereto (Filed With SEC on March 14, 2019)
- Common Stock Purchase Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
- Common Stock Purchase Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)
- Registration Rights Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
- Form of Warrant to Purchase Common Stock for Innovatus (Filed With SEC on March 14, 2019)
- Registration Rights Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)
- Form of Warrant to Purchase Common Stock for Service Providers (Filed With SEC on November 21, 2018)
- Omnibus Amendment to Warrants to Purchase Series D Preferred Stock by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Omnibus Amendment to Warrants to Purchase Series B-1 Preferred Stock by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Omnibus Amendment to Convertible Promissory Notes by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Bionano Genomics, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on August 15, 2018)
- Fifth Amended and Restated Investors Rights Agreement, dated August 5, 2016 as amended (Filed With SEC on August 15, 2018)